The United States Amino Acid API Market was valued at USD 1.23 Billion in 2024 and is projected to reach USD 1.98 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period (2024–2032). This growth is being driven by rising chronic disease prevalence, increasing adoption of targeted therapies, and the expanding role of pharmaceutical-grade amino acids in parenteral nutrition, biologics manufacturing, and biopharmaceutical applications across the United States.

As the pharmaceutical industry accelerates toward precision medicine and advanced therapeutic solutions, the spotlight is on the key manufacturers who are driving innovation, production excellence, and high-purity amino acid supply chains. In this blog, we profile the Top 10 Companies in the United States Amino Acid API Industry—a mix of global pharma leaders, specialty chemical producers, and contract manufacturing pioneers shaping the future of amino acid-based medicine.

---

🕁 1. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: High-Purity L-Amino Acids, GMP-Certified APIs, Custom Amino Acid Formulations

Thermo Fisher Scientific stands out as a dominant force in the United States amino acid API landscape. The company brings an extensive portfolio of pharmaceutical-grade amino acids serving drug development, parenteral nutrition, and cell culture media applications. Its robust manufacturing infrastructure and deep regulatory expertise make it a preferred partner for pharmaceutical companies across North America.

Key Strengths:

• Comprehensive GMP-certified amino acid product portfolio

• Strong presence in research, clinical, and commercial manufacturing segments

• Advanced quality control systems ensuring purity levels exceeding 99.9%

Download FREE Sample Report:
United States Amino Acid API Market – View in Detailed Research Report

---

&#9picture_9; 2. Ajinomoto Bio-Pharma Services

Headquarters: San Diego, California, USA (Japan/U.S. Operations)
Key Offering: Fermentation-Derived Amino Acid APIs, Custom Synthesis, CDMO Services

Ajinomoto Bio-Pharma Services is one of the most recognized names in amino acid production globally, with significant operations serving the U.S. pharmaceutical market. Its proprietary fermentation technologies enable high-yield, high-purity production of essential and conditionally essential amino acids. The company’s integrated CDMO capabilities position it uniquely to support both early-stage development and large-scale commercial supply.

Key Strengths:

• Decades of expertise in fermentation-based amino acid manufacturing

• Full-service CDMO offerings from API development to finished dosage forms

• Strategic U.S. facility expansions to meet growing pharmaceutical demand

---

&#8cl; 3. Sigma-Aldrich Co. LLC (Merck KGaA)

Headquarters: St. Louis, Missouri, USA (Part of Merck KGaA, Germany)
Key Offering: Research-Grade and Pharmaceutical-Grade Amino Acids, Custom Synthesis

Operating under the broader Merck KGaA umbrella, Sigma-Aldrich is a cornerstone supplier of amino acid APIs to pharmaceutical companies, research institutions, and biotechnology firms across the United States. The company’s extensive catalog spans hundreds of amino acid variants, from standard L-form amino acids to specialty non-proteinogenic derivatives increasingly sought in peptide drug development.

Key Strengths:

• One of the broadest amino acid API catalogs available in North America

• R&D investment exceeding 10% of annual revenues to develop novel amino acid derivatives

• Established partnerships with top-tier U.S. pharmaceutical manufacturers

Download FREE Sample Report:
United States Amino Acid API Market – View in Detailed Research Report

---

&#7th; 4. Bachem Holding AG

Headquarters: Bubendorf, Switzerland (U.S. Operations in Torrance, California)
Key Offering: Peptide APIs, Protected Amino Acids, Custom Peptide Synthesis

Bachem is a globally recognized leader in peptide chemistry, and its U.S. operations serve a rapidly growing market for amino acid-based peptide therapeutics. As peptide drugs gain increasing regulatory approvals in the United States, Bachem’s specialization in protected amino acid building blocks and custom synthesis positions it at the very heart of next-generation drug manufacturing.

Key Strengths:

• Specialized expertise in complex peptide and amino acid API synthesis

• State-of-the-art U.S. manufacturing facilities with full GMP compliance

• Growing pipeline of peptide-based drug projects driving demand for amino acid building blocks

---

&#6th; 5. Evonik Industries AG

Headquarters: Essen, Germany (Significant U.S. Operations)
Key Offering: Pharmaceutical-Grade Amino Acids, Excipients, Drug Delivery Components

Evonik Industries has established a strong footprint in the United States amino acid API sector, offering pharmaceutical-grade amino acids that serve both active ingredient and excipient functions in drug formulations. The company’s focus on sustainable manufacturing and advanced fermentation processes has made it a preferred supplier for biologics manufacturers and specialty pharmaceutical companies.

Key Strengths:

• Advanced fermentation and biotransformation technologies for amino acid production

• Strong focus on non-animal-derived amino acids addressing clean-label market demands

• Active collaborations with U.S. biotech and pharmaceutical firms on custom API solutions

---

&#5th; 6. CordenPharma International

Headquarters: Plankstadt, Germany (U.S. Operations)
Key Offering: Amino Acid APIs, Peptide Manufacturing, Lipid-Based Drug Delivery

CordenPharma has built a reputation as one of the most reliable contract development and manufacturing organizations serving the amino acid API space in the United States. The company provides end-to-end services from early development through commercial-scale manufacturing, with a particular strength in amino acid chemistry and peptide APIs that are increasingly central to oncology and rare disease therapeutics.

Key Strengths:

• Dedicated amino acid and peptide manufacturing expertise across multiple facilities

• Proven track record supporting FDA-regulated drug approvals

• Expanding U.S. capacity to meet accelerating demand for specialty amino acid APIs

---

&#4th; 7. Pfizer CentreOne

Headquarters: New York, New York, USA
Key Offering: Sterile Injectable Amino Acid APIs, Parenteral Nutrition Components, Contract Manufacturing

Pfizer CentreOne, the contract manufacturing arm of Pfizer Inc., leverages world-class infrastructure to supply high-purity amino acid APIs for parenteral nutrition and injectable pharmaceutical applications. Given the critical role amino acids play in intravenous nutrition therapy—a segment that saw an 18% year-over-year increase in demand in 2024—Pfizer CentreOne’s manufacturing capabilities represent a significant competitive advantage in this space.

Key Strengths:

• World-class sterile manufacturing capabilities for injectable amino acid formulations

• Deep regulatory expertise with FDA and international health authorities

• Strong supply chain infrastructure ensuring consistent API availability

Download FREE Sample Report:
United States Amino Acid API Market – View in Detailed Research Report

---

&#3rd; 8. Lonza Group Ltd

Headquarters: Basel, Switzerland (Major U.S. Operations in Bend, Oregon and Greenwood, South Carolina)
Key Offering: Amino Acid APIs, Biopharmaceutical Ingredients, Custom Bioprocessing

Lonza is a globally recognized CDMO and API manufacturer with substantial U.S. operations dedicated to amino acid and biopharmaceutical ingredient supply. The company’s investments in sustainable fermentation and bioprocessing technologies make it particularly well positioned to serve the biologics and cell therapy segments, where high-purity amino acids are critical components of cell culture media and drug formulations.

Key Strengths:

• Major U.S. manufacturing hubs with GMP-compliant amino acid production capabilities

• Specialized expertise in amino acids for cell culture and biologic drug applications

• R&D investments focused on sustainable sourcing and novel amino acid derivative development

---

&#2nd; 9. Catalent Inc.

Headquarters: Somerset, New Jersey, USA
Key Offering: Amino Acid-Based Drug Formulations, Oral and Injectable API Services, Clinical Supply

Catalent is one of the largest pharmaceutical services companies in the United States, providing comprehensive drug development and manufacturing solutions that include amino acid API handling, formulation, and delivery. As personalized medicine and targeted therapies continue to drive amino acid API demand, Catalent’s broad service platform—spanning oral, injectable, and biologics formulations—makes it an indispensable partner for pharmaceutical innovators.

Key Strengths:

• Extensive U.S. manufacturing network covering multiple formulation types

• Strong clinical supply capabilities supporting amino acid API-based drug trials

• Growing portfolio of biologics and specialty pharma projects incorporating amino acid building blocks

---

&#1st; 10. AMRI Global (Albany Molecular Research Inc.)

Headquarters: Albany, New York, USA
Key Offering: Custom Amino Acid Synthesis, API Development, Contract Research and Manufacturing

AMRI Global rounds out the top ten with its specialized capabilities in custom amino acid synthesis and contract research services. The company serves pharmaceutical and biotech clients across the United States who require tailored amino acid API solutions for novel drug candidates. AMRI’s particular strength lies in handling complex, non-standard amino acid derivatives that are increasingly prominent in peptide therapeutics and precision medicine applications.

Key Strengths:

• Expertise in complex and non-proteinogenic amino acid custom synthesis

• Integrated contract research and manufacturing services for end-to-end project support

• Strong focus on personalized medicine applications driving next-generation amino acid API demand

Get Full Report Here:
United States Amino Acid API Market – View in Detailed Research Report

---

🌎 Outlook: The Future of the U.S. Amino Acid API Market Is Smarter and More Therapeutic

The United States amino acid API market is undergoing a meaningful transformation. While established amino acids such as lysine, methionine, and glutamate continue to anchor market volume, the industry is directing significant investment toward high-purity specialty derivatives, advanced fermentation technologies, and novel therapeutic applications that are reshaping pharmaceutical manufacturing.

📈 Key Trends Shaping the Market:

• Rapid expansion of peptide-based therapeutics driving demand for protected and modified amino acid APIs

• Growing adoption of continuous manufacturing technologies reducing production costs by up to 30%

• Increasing regulatory support for GMP-certified amino acids in biologics and parenteral applications

• Rising demand for non-animal-derived, sustainably sourced amino acid APIs across pharmaceutical and nutraceutical segments

• Expansion of amino acid-functionalized drug delivery systems showing up to 80% improvement in tumor targeting efficiency

Get Full Report Here:
United States Amino Acid API Market – View in Detailed Research Report

The companies profiled above are not only supplying the building blocks of modern medicine—they’re spearheading the next generation of therapeutic innovation in the United States pharmaceutical industry.